Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03277729
Brief Title: A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

First Submitted : September 7, 2017
First Submitted that Met QC Criteria : September 7, 2017
First Posted : September 11, 2017

Last Update Submitted that Met QC Criteria : July 9, 2021
Last Update Posted : July 13, 2021